Erasca, Inc. (ERAS)
Erasca, Inc. (ERAS) is a Healthcare stock tracked by StreetAlpha. ERAS reports earnings on Wed, Nov 11, 2026. Analyst consensus is Buy, based on the latest ratings from 4 firms (2 buy, 2 hold, 0 sell). Over the past 90 days StreetAlpha recorded 2 whale options trades in ERAS, 50% of them bullish and 50% bearish. In the past 30 days there were 4 dark pool prints.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Aug 14 | B of A Securities | Target raised | Hold | — |
| Aug 13 | Guggenheim | Maintained | Buy | — |
| Aug 12 | HC Wainwright & Co. | Maintained | Buy | — |
| Jul 20 | Morgan Stanley | Maintained | Hold | — |
| Jul 14 | B of A Securities | Target raised | Hold | — |
Whale Options Flow
90DDark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ERAS is in one of them and how their past ERAS trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered ERAS in an article yet. Here's the latest on the wider market.